Dr Daniela Ulgiati completed her Bachelor of Science with Honours majoring in pharmacology and physiology and a PhD in immunology and biochemistry at The University of Western Australia. She then won an United States Arthritis Foundation Fellowship for a four year post-doctoral fellowship position at the University of Colorado in Denver. In 2002 she returned to UWA to take up a research and lecturing fellowship and was instated in her current teaching and research position in late 2007.

NIH
Alliance for Lupus Research
Cancer Council of Western Australia
NHMRC

Collaborators

Prof Lawrie Abraham, UWA
Dr Paul Besant, UWA
Dr Peter Hollingsworth, PathWest
Dr Kevin Marchbank, University of Newcastle, United Kingdom
Prof Michael Holers, University of Colorado, USA
Dr Susan Boackle, University of Colorado, USA
Dr Betty Tsao, University of California, Los Angeles, USA

Post-doctorate Group Members

Dr Mark Cruikshanks
Dr Mahdad Karimi

GENE2204 Principles of Genetics (Unit Co-ordinator)
GENE2230 Molecular Genetics (Unit Co-ordinator)
GENE3330 Molecular Genetics and Genomics
BIOC2202 Biochemical Regulation of Cell Function
Graduate Entry Medical Program (GEMP)
IDNT/PODI1134 Introduction to Normal Systems
IMED2210 Normal Systems
BIOC3351 Molecular and Structural Biochemistry
GENE2204 Principles of Genetics
BIOC3352 Cellular and Metabolic Biochemistry
IMED1113 Molecules, Genes and Cells

Dr Ulgiati’s research interest is in the role of complement in health and disease. Her ambition is to clarify the roles of complement and B cell biology in autoimmune disease, using Systemic Lupus Erythematosus (SLE) as a model for this and other autoimmune diseases. Currently, the auto-immune diseases that this research is focused on are lupus and rheumatoid arthritis and it is moving towards the study of lymphomas and other cancers. The work performed in Dr Ulgiati’s laboratory is varied and includes a wide range of molecular biological, biochemical, immunological and genetic techniques. Some of which include Genotyping, Chomatin Assays, ChIP assays, DNA sequencing and cloning, cell culture, stable and transient transfection assays, PCR, DNA binding assays, proteomic analysis, and FACS analysis.